Anan Ashraf

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.

The data show that the drug, in combination with others, reduced the risk of disease progression or death by about 50%.

Martin Shkreli noted that similar fears of cancer risk previously existed in association with GLP-1 class drugs.

Rivian is now preparing for one of its most important product launches to date.

The investigation comes months after Compass completed its $1.6 billion acquisition of Anywhere Real Estate earlier this year, creating Compass International Holdings.

SpaceX is launching the largest U.S. IPO in history by pricing shares at $135, raising $75 billion to fuel rockets, Starlink and AI, while valuing the company at $1.77 trillion and keeping Elon Musk in firm control.

In a statement, Siebel, who also serves as chairman, said the company now has a clear strategy.

Tesla CEO Elon Musk had expressed disappointment with the EV-maker's market share in Japan as early as 2024, calling it "remarkably low.”

The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.